Announcements Trials
Browse Landscape

Phase

Phase 2 71Phase 1 28Phase 1/2 12Phase EARLY_PHASE1 5Phase NA 4Phase 3 4Phase 2/3 3

Status

Unknown 2Completed 2

Sponsor Class

INDUSTRY 24OTHER 4NIH 3NETWORK 2OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Neoplastic Cells, Circulating 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Lapatinib × Clear all
NCT01619111 2024-06-04

DETECT III

University of Ulm

Phase 3 Completed
105 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT01104571 2018-09-17

EPHOS-B

Institute of Cancer Research, United Kingdom

Phase 3 Unknown
257 enrolled
Breast

Breast Neoplasms

NCT02394496 2016-06-15

OVER

Consorzio Oncotech

Phase 3 Unknown
396 enrolled
Breast

Breast Neoplasms

NCT00567554 2016-02-10

GeparQuinto

GBG Forschungs GmbH

Phase 3 Completed
2,600 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡